{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:49:30Z","timestamp":1787240970666,"version":"build-2736575974"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00105-021-04853-x","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T05:03:36Z","timestamp":1625547816000},"page":"658-665","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Pathogenese der Hidradenitis suppurativa\/Acne inversa","Pathogenesis of hidradenitis suppurativa\/acne inversa"],"prefix":"10.1007","volume":"72","author":[{"given":"G.","family":"Nikolakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kokolakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kaleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Wolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hunger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. C.","family":"Zouboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"key":"4853_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/0929866526666190822165812","volume":"27","author":"JK Boparai","year":"2019","unstructured":"Boparai\u00a0JK, Sharma\u00a0PK (2019) Mini review on antimicrobial peptides, sources, mechanism and recent applications. Protein Pept Lett 27:4\u201316. https:\/\/doi.org\/10.2174\/0929866526666190822165812","journal-title":"Protein Pept Lett"},{"key":"4853_CR2","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/jid.2012.472","volume":"133","author":"F Canoui-Poitrine","year":"2013","unstructured":"Canoui-Poitrine\u00a0F, Le Thuaut\u00a0A, Revuz\u00a0JE et al (2013) Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a\u00a0cross-sectional study. J\u00a0Invest Dermatol 133:1506\u20131511. https:\/\/doi.org\/10.1038\/jid.2012.472","journal-title":"J Invest Dermatol"},{"key":"4853_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1001\/archdermatol.2011.315","volume":"148","author":"B Dr\u00e9no","year":"2012","unstructured":"Dr\u00e9no\u00a0B, Khammari\u00a0A, Brocard\u00a0A et\u00a0al (2012) Hidradenitis suppurativa: the role of deficient cutaneous innate immunity. Arch Dermatol 148:182\u2013186. https:\/\/doi.org\/10.1001\/archdermatol.2011.315","journal-title":"Arch Dermatol"},{"key":"4853_CR4","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/j.jid.2019.10.025","volume":"140","author":"S Duchatelet","year":"2020","unstructured":"Duchatelet\u00a0S, Miskinyte\u00a0S, Delage\u00a0M et\u00a0al (2020) Low prevalence of GSC gene mutations in a\u00a0large cohort of predominantly caucasian patients with hidradenitis suppurativa. J\u00a0Invest Dermatol 140:2085\u20132088.e14. https:\/\/doi.org\/10.1016\/j.jid.2019.10.025","journal-title":"J Invest Dermatol"},{"key":"4853_CR5","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/j.1365-2133.2011.10765.x","volume":"166","author":"VU Emelianov","year":"2012","unstructured":"Emelianov\u00a0VU, Bechara\u00a0FG, Gl\u00e4ser\u00a0R et al (2012) Immunohistological pointers to a\u00a0possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa\/acne inversa. Br J Dermatol 166:1023\u20131034. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10765.x","journal-title":"Br J Dermatol"},{"key":"4853_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2133.1985.tb02037.x","volume":"113","author":"J Fitzsimmons","year":"1985","unstructured":"Fitzsimmons\u00a0J, Guilbert\u00a0P, Fitzsimmons\u00a0E (1985) Evidence of genetic factors in hidradenitis suppurativa. Br J Dermatol 113:1\u20138. https:\/\/doi.org\/10.1111\/j.1365-2133.1985.tb02037.x","journal-title":"Br J Dermatol"},{"key":"4853_CR7","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/sj.jid.5700272","volume":"126","author":"M Gao","year":"2006","unstructured":"Gao\u00a0M, Wang\u00a0PG, Cui\u00a0Y et\u00a0al (2006) Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1\u20131q25.3. J\u00a0Invest Dermatol 126:1302\u20131306. https:\/\/doi.org\/10.1038\/sj.jid.5700272","journal-title":"J Invest Dermatol"},{"key":"4853_CR8","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/bjd.19121","volume":"183","author":"S Garcovich","year":"2020","unstructured":"Garcovich\u00a0S, Tricarico\u00a0PM, Nait-Meddour\u00a0C et al (2020) Novel nicastrin mutation in hidradenitis suppurativa-Dowling-Degos disease clinical phenotype: more than just clinical overlap? Br J Dermatol 183:758\u2013759. https:\/\/doi.org\/10.1111\/bjd.19121","journal-title":"Br J Dermatol"},{"key":"4853_CR9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/bjd.15939","volume":"178","author":"A Garg","year":"2018","unstructured":"Garg\u00a0A, Papagermanos\u00a0V, Midura\u00a0M, Strunk\u00a0A (2018) Incidence of hidradenitis suppurativa among tobacco smokers: a\u00a0population-based retrospective analysis in the U.S.A. Br J Dermatol 178:709\u2013714. https:\/\/doi.org\/10.1111\/bjd.15939","journal-title":"Br J Dermatol"},{"key":"4853_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/bjd.17093","volume":"180","author":"TD Gauntner","year":"2019","unstructured":"Gauntner\u00a0TD (2019) Hormonal, stem cell and Notch signalling as possible mechanisms of disease in hidradenitis suppurativa: a\u00a0systems-level transcriptomic analysis. Br J Dermatol 180:203\u2013204. https:\/\/doi.org\/10.1111\/bjd.17093","journal-title":"Br J Dermatol"},{"key":"4853_CR11","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi\u00a0K, Balato\u00a0A, Enerb\u00e4ck\u00a0C, Sabat\u00a0R (2021) Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet 397:754\u2013766. https:\/\/doi.org\/10.1016\/S0140-6736(21)00184-7","journal-title":"Lancet"},{"key":"4853_CR12","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.jid.2016.04.021","volume":"136","author":"EJ Giamarellos-Bourboulis","year":"2016","unstructured":"Giamarellos-Bourboulis\u00a0EJ, Platzer\u00a0M, Karagiannidis\u00a0I et al (2016) High copy numbers of \u03b2\u2011Defensin cluster on 8p23.1, confer genetic susceptibility, and modulate the physical course of hidradenitis suppurativa\/acne Inversa. J\u00a0Invest Dermatol 136:1592\u20131598. https:\/\/doi.org\/10.1016\/j.jid.2016.04.021","journal-title":"J Invest Dermatol"},{"key":"4853_CR13","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jaad.2019.08.090","volume":"82","author":"SR Goldburg","year":"2020","unstructured":"Goldburg\u00a0SR, Strober\u00a0BE, Payette\u00a0MJ (2020) Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis. J\u00a0Am Acad Dermatol 82:1045\u20131058. https:\/\/doi.org\/10.1016\/j.jaad.2019.08.090","journal-title":"J Am Acad Dermatol"},{"key":"4853_CR14","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3201\/eid2012.140064","volume":"20","author":"H Guet-Revillet","year":"2014","unstructured":"Guet-Revillet\u00a0H, Coignard-Biehler\u00a0H, Jais\u00a0JP et al (2014) Bacterial pathogens associated with hidradenitis suppurativa, France. Emerg Infect Dis 20:1990\u20131998. https:\/\/doi.org\/10.3201\/eid2012.140064","journal-title":"Emerg Infect Dis"},{"key":"4853_CR15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/cid\/cix285","volume":"65","author":"H Guet-Revillet","year":"2017","unstructured":"Guet-Revillet\u00a0H, Jais\u00a0JP, Ungeheuer\u00a0MN et al (2017) The microbiological landscape of anaerobic infections in hidradenitis suppurativa: a prospective metagenomic study. Clin Infect Dis 65:282\u2013291. https:\/\/doi.org\/10.1093\/cid\/cix285","journal-title":"Clin Infect Dis"},{"key":"4853_CR16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11154-016-9328-5","volume":"17","author":"W Gulliver","year":"2016","unstructured":"Gulliver\u00a0W, Zouboulis\u00a0CC, Prens\u00a0E et al (2016) Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guidelines for hidradenitis suppurativa. Rev Endocr Metab Disord 17:343\u2013351. https:\/\/doi.org\/10.1007\/s11154-016-9328-5","journal-title":"Rev Endocr Metab Disord"},{"key":"4853_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/jdv.16962","volume":"35","author":"S Hessam","year":"2021","unstructured":"Hessam\u00a0S, Gambichler\u00a0T, Skrygan\u00a0M et\u00a0al (2021) Increased expression profile of NCSTN, notch and PI3K\/AKT3 in hidradenitis suppurativa. J\u00a0Eur Acad Dermatol Venereol 35:203\u2013210. https:\/\/doi.org\/10.1111\/jdv.16962","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4853_CR18","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/j.jid.2016.04.036","volume":"136","author":"C Hotz","year":"2016","unstructured":"Hotz\u00a0C, Boniotto\u00a0M, Guguin\u00a0A et\u00a0al (2016) Intrinsic defect in keratinocyte function leads to inflammation in hidradenitis suppurativa. J\u00a0Invest Dermatol 136:1768\u20131780. https:\/\/doi.org\/10.1016\/j.jid.2016.04.036","journal-title":"J Invest Dermatol"},{"key":"4853_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2133.2007.08425.x","volume":"158","author":"RE Hunger","year":"2008","unstructured":"Hunger\u00a0RE, Surovy\u00a0AM, Hassan\u00a0AS et al (2008) Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C\u2011type lectin receptor. Br J Dermatol 158:691\u2013697. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08425.x","journal-title":"Br J Dermatol"},{"key":"4853_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.det.2015.07.002","volume":"34","author":"JR Ingram","year":"2016","unstructured":"Ingram\u00a0JR (2016) The genetics of hidradenitis suppurativa. Dermatol Clin 34:23\u201328. https:\/\/doi.org\/10.1016\/j.det.2015.07.002","journal-title":"Dermatol Clin"},{"key":"4853_CR21","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/bjd.12048","volume":"168","author":"JR Ingram","year":"2013","unstructured":"Ingram\u00a0JR, Wood\u00a0M, John\u00a0B et al (2013) Absence of pathogenic \u03b3\u2011secretase mutations in a\u00a0South Wales cohort of familial and sporadic hidradenitis suppurativa (acne inversa). Br J Dermatol 168:874\u2013876. https:\/\/doi.org\/10.1111\/bjd.12048","journal-title":"Br J Dermatol"},{"key":"4853_CR22","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jid.2018.10.020","volume":"139","author":"A Jenei","year":"2019","unstructured":"Jenei\u00a0A, Dajnoki\u00a0Z, Medgyesi\u00a0B et al (2019) Apocrine gland-rich skin has a\u00a0non-inflammatory IL-17-related immune milieu, that turns to inflammatory IL-17-mediated disease in hidradenitis Suppurativa. J\u00a0Invest Dermatol 139:964\u2013968. https:\/\/doi.org\/10.1016\/j.jid.2018.10.020","journal-title":"J Invest Dermatol"},{"key":"4853_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/1203475419852049","volume":"23","author":"AH Jfri","year":"2019","unstructured":"Jfri\u00a0AH, O\u2019Brien\u00a0EA, Litvinov\u00a0IV et\u00a0al (2019) Hidradenitis suppurativa: comprehensive review of predisposing genetic mutations and changes. J\u00a0Cutan Med Surg 23:519\u2013527. https:\/\/doi.org\/10.1177\/1203475419852049","journal-title":"J Cutan Med Surg"},{"key":"4853_CR24","doi-asserted-by":"publisher","DOI":"10.1159\/000517017","author":"KP Kaleta","year":"2021","unstructured":"Kaleta KP, Nikolakis G, Hossini A et al (2021) Metabolic disorders\/obesity is a\u00a0primary risk factor in hidradenitis suppurativa\u2014an immunohistochemical real-world approach. Dermatology. https:\/\/doi.org\/10.1159\/000517017","journal-title":"Dermatology"},{"key":"4853_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11154-016-9366-z","volume":"17","author":"I Karagiannidis","year":"2016","unstructured":"Karagiannidis\u00a0I, Nikolakis\u00a0G, Sabat\u00a0R, Zouboulis\u00a0CC (2016) Hidradenitis suppurativa\/Acne inversa: an endocrine skin disorder? Rev Endocr Metab Disord 17:335\u2013341. https:\/\/doi.org\/10.1007\/s11154-016-9366-z","journal-title":"Rev Endocr Metab Disord"},{"key":"4853_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.det.2015.08.005","volume":"34","author":"I Karagiannidis","year":"2016","unstructured":"Karagiannidis\u00a0I, Nikolakis\u00a0G, Zouboulis\u00a0CC (2016) Endocrinologic aspects of hidradenitis suppurativa. Dermatol Clin 34:45\u201349. https:\/\/doi.org\/10.1016\/j.det.2015.08.005","journal-title":"Dermatol Clin"},{"key":"4853_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai\u00a0T, Akira\u00a0S (2010) The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol 11:373\u2013384. https:\/\/doi.org\/10.1038\/ni.1863","journal-title":"Nat Immunol"},{"key":"4853_CR28","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa1504370","volume":"375","author":"AB Kimball","year":"2016","unstructured":"Kimball\u00a0AB, Okun\u00a0MM, Williams\u00a0DA et\u00a0al (2016) Two phase 3 trials of adalimumab for hidradenitis suppurativa. N\u00a0Engl J Med 375:422\u2013434. https:\/\/doi.org\/10.1056\/NEJMoa1504370","journal-title":"N Engl J Med"},{"key":"4853_CR29","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1159\/000508787","volume":"236","author":"G Kokolakis","year":"2020","unstructured":"Kokolakis\u00a0G, Wolk\u00a0K, Schneider-Burrus\u00a0S et al (2020) Delayed diagnosis of hidradenitis suppurativa and its effect on patients and healthcare system. Dermatology 236:421\u2013430. https:\/\/doi.org\/10.1159\/000508787","journal-title":"Dermatology"},{"key":"4853_CR30","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1600-0625.2008.00712_1.x","volume":"17","author":"H Kurzen","year":"2008","unstructured":"Kurzen\u00a0H, Kurokawa\u00a0I, Jemec\u00a0GBE et\u00a0al (2008) What causes hidradenitis suppurativa? Exp Dermatol 17:455\u2013456. https:\/\/doi.org\/10.1111\/j.1600-0625.2008.00712_1.x","journal-title":"Exp Dermatol"},{"key":"4853_CR31","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1111\/ajd.13107","volume":"61","author":"X Li","year":"2020","unstructured":"Li\u00a0X, Jiang\u00a0L, Huang\u00a0Y et\u00a0al (2020) A gene dysfunction module reveals the underlying pathogenesis of hidradenitis suppurativa: an update. Australas J Dermatol 61:e10\u2013e14. https:\/\/doi.org\/10.1111\/ajd.13107","journal-title":"Australas J Dermatol"},{"key":"4853_CR32","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jid.2019.08.445","volume":"140","author":"HB Naik","year":"2020","unstructured":"Naik\u00a0HB, Jo\u00a0JH, Paul\u00a0M, Kong\u00a0HH (2020) Skin microbiota perturbations are distinct and disease severity-dependent in hidradenitis suppurativa. J\u00a0Invest Dermatol 140:922\u2013925.e3. https:\/\/doi.org\/10.1016\/j.jid.2019.08.445","journal-title":"J Invest Dermatol"},{"key":"4853_CR33","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.jaad.2015.07.041","volume":"73","author":"G Nikolakis","year":"2015","unstructured":"Nikolakis\u00a0G, Join-Lambert\u00a0O, Karagiannidis\u00a0I et al (2015) Bacteriology of hidradenitis suppurativa\/acne inversa: a review. J\u00a0Am Acad Dermatol 73:S12\u2013S18. https:\/\/doi.org\/10.1016\/j.jaad.2015.07.041","journal-title":"J Am Acad Dermatol"},{"key":"4853_CR34","doi-asserted-by":"publisher","DOI":"10.1159\/000509873","author":"G Nikolakis","year":"2020","unstructured":"Nikolakis G, Kaleta KP, Vaiopoulos AG et\u00a0al (2020) Phenotypes and Pathophysiology of Syndromic Hidradenitis Suppurativa: Different Faces of the Same Disease? A Systematic Review. Dermatology. https:\/\/doi.org\/10.1159\/000509873","journal-title":"Dermatology"},{"key":"4853_CR35","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1007\/s00105-020-04679-z","volume":"71","author":"G Nikolakis","year":"2020","unstructured":"Nikolakis\u00a0G, Karagiannidis\u00a0I, Vaiopoulos\u00a0AG et\u00a0al (2020) Endocrinological mechanisms in the pathophysiology of hidradenitis suppurativa. Hautarzt 71:762\u2013771. https:\/\/doi.org\/10.1007\/s00105-020-04679-z","journal-title":"Hautarzt"},{"key":"4853_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s40257-019-00442-w","volume":"20","author":"G Nikolakis","year":"2019","unstructured":"Nikolakis\u00a0G, Kyrgidis\u00a0A, Zouboulis\u00a0CC (2019) Is there a\u00a0role for antiandrogen therapy for hidradenitis suppurativa? A systematic review of published data. Am J Clin Dermatol 20:503\u2013513. https:\/\/doi.org\/10.1007\/s40257-019-00442-w","journal-title":"Am J Clin Dermatol"},{"key":"4853_CR37","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.micro.57.030502.090720","volume":"57","author":"MR Parsek","year":"2003","unstructured":"Parsek\u00a0MR, Singh\u00a0PK (2003) Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 57:677\u2013701. https:\/\/doi.org\/10.1146\/annurev.micro.57.030502.090720","journal-title":"Annu Rev Microbiol"},{"key":"4853_CR38","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/bjd.15007","volume":"176","author":"HC Ring","year":"2017","unstructured":"Ring\u00a0HC, Bay\u00a0L, Nilsson\u00a0M et\u00a0al (2017) Bacterial biofilm in chronic lesions of hidradenitis suppurativa. Br J Dermatol 176:993\u20131000. https:\/\/doi.org\/10.1111\/bjd.15007","journal-title":"Br J Dermatol"},{"key":"4853_CR39","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1111\/jdv.15597","volume":"33","author":"HC Ring","year":"2019","unstructured":"Ring\u00a0HC, Sigsgaard\u00a0V, Thorsen\u00a0J et\u00a0al (2019) The microbiome of tunnels in hidradenitis suppurativa patients. J\u00a0Eur Acad Dermatol Venereol 33:1775\u20131780. https:\/\/doi.org\/10.1111\/jdv.15597","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4853_CR40","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1001\/jamadermatol.2017.0904","volume":"153","author":"HC Ring","year":"2017","unstructured":"Ring\u00a0HC, Thorsen\u00a0J, Saunte\u00a0DM et\u00a0al (2017) The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls. JAMA Dermatol 153:897\u2013905. https:\/\/doi.org\/10.1001\/jamadermatol.2017.0904","journal-title":"JAMA Dermatol"},{"key":"4853_CR41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/jdv.14538","volume":"32","author":"HC Ring","year":"2018","unstructured":"Ring\u00a0HC, Thorsen\u00a0J, Saunte\u00a0DM et\u00a0al (2018) Moderate to severe hidradenitis suppurativa patients do not have an altered bacterial composition in peripheral blood compared to healthy controls. J\u00a0Eur Acad Dermatol Venereol 32:125\u2013128. https:\/\/doi.org\/10.1111\/jdv.14538","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4853_CR42","doi-asserted-by":"publisher","first-page":"e31810","DOI":"10.1371\/journal.pone.0031810","volume":"7","author":"R Sabat","year":"2012","unstructured":"Sabat\u00a0R, Chanwangpong\u00a0A, Schneider-Burrus\u00a0S et al (2012) Increased prevalence of metabolic syndrome in patients with Acne inversa. Plos One 7:e31810. https:\/\/doi.org\/10.1371\/journal.pone.0031810","journal-title":"Plos One"},{"key":"4853_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0149-1","author":"R Sabat","year":"2020","unstructured":"Sabat\u00a0R, Jemec\u00a0GBE, Matusiak \u0141 et\u00a0al (2020) Hidradenitis suppurativa. Nat Rev Dis Primers. https:\/\/doi.org\/10.1038\/s41572-020-0149-1","journal-title":"Nat. Rev. Dis. Primers"},{"key":"4853_CR44","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00281-019-00742-7","volume":"41","author":"R Sabat","year":"2019","unstructured":"Sabat\u00a0R, Wolk\u00a0K, Loyal\u00a0L et\u00a0al (2019) T cell pathology in skin inflammation. Semin Immunopathol 41:359\u2013377. https:\/\/doi.org\/10.1007\/s00281-019-00742-7","journal-title":"Semin Immunopathol"},{"key":"4853_CR45","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/bjd.12105","volume":"168","author":"A Savva","year":"2013","unstructured":"Savva\u00a0A, Kanni\u00a0T, Damoraki\u00a0G et al (2013) Impact of Toll-like receptor\u20114 and tumour necrosis factor gene polymorphisms in patients with hidradenitis suppurativa. Br J Dermatol 168:311\u2013317. https:\/\/doi.org\/10.1111\/bjd.12105","journal-title":"Br J Dermatol"},{"key":"4853_CR46","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","volume":"65","author":"C Schlapbach","year":"2011","unstructured":"Schlapbach\u00a0C, H\u00e4nni\u00a0T, Yawalkar\u00a0N, Hunger\u00a0RE (2011) Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa. J\u00a0Am Acad Dermatol 65:790\u2013798. https:\/\/doi.org\/10.1016\/j.jaad.2010.07.010","journal-title":"J Am Acad Dermatol"},{"key":"4853_CR47","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1111\/jdv.16783","volume":"35","author":"S Schneider-Burrus","year":"2021","unstructured":"Schneider-Burrus\u00a0S, Lux\u00a0G, van der Linde\u00a0K et al (2021) Hidradenitis suppurativa-prevalence analyses of German statutory health insurance data. J\u00a0Eur Acad Dermatol Venereol 35:e32\u2013e35. https:\/\/doi.org\/10.1111\/jdv.16783","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4853_CR48","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3389\/FMED.2021.676241","volume":"8","author":"S Schneider-Burrus","year":"2021","unstructured":"Schneider-Burrus\u00a0S, Tsaousi\u00a0A, Barbus\u00a0S et al (2021) Features associated with quality of life impairment in hidradenitis suppurativa patients. Front Med 8:538. https:\/\/doi.org\/10.3389\/FMED.2021.676241","journal-title":"Front Med"},{"key":"4853_CR49","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1159\/000448838","volume":"232","author":"S Schneider-Burrus","year":"2017","unstructured":"Schneider-Burrus\u00a0S, Witte-Haendel\u00a0E, Christou\u00a0D et al (2017) High prevalence of back pain and axial spondyloarthropathy in patients with hidradenitis suppurativa. Dermatology 232:606\u2013612. https:\/\/doi.org\/10.1159\/000448838","journal-title":"Dermatology"},{"key":"4853_CR50","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/bjd.13777","volume":"173","author":"G Shalom","year":"2015","unstructured":"Shalom\u00a0G, Freud\u00a0T, Harman-Boehm\u00a0I et al (2015) Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207\u00a0patients. Br J Dermatol 173:464\u2013470. https:\/\/doi.org\/10.1111\/bjd.13777","journal-title":"Br J Dermatol"},{"key":"4853_CR51","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jamadermatol.2020.3630","volume":"156","author":"KR Van Straalen","year":"2020","unstructured":"Van Straalen\u00a0KR, Prens\u00a0EP, Willemsen\u00a0G et al (2020) Contribution of genetics to the susceptibility to hidradenitis suppurativa in a\u00a0large, cross-sectional Dutch twin cohort. JAMA Dermatol 156:1359\u20131362. https:\/\/doi.org\/10.1001\/jamadermatol.2020.3630","journal-title":"JAMA Dermatol"},{"key":"4853_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.00892","volume":"10","author":"PM Tricarico","year":"2019","unstructured":"Tricarico\u00a0PM, Boniotto\u00a0M, Genovese\u00a0G et\u00a0al (2019) An integrated approach to unravel hidradenitis suppurativa etiopathogenesis. Front Immunol 10:1\u201313. https:\/\/doi.org\/10.3389\/fimmu.2019.00892","journal-title":"Front Immunol"},{"key":"4853_CR53","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S1471-4906(01)01985-8","volume":"22","author":"HD Volk","year":"2001","unstructured":"Volk HD, Asadullah K, Gallagher G et al (2001) IL-10 and its homologs: Important immune mediators and emerging immunotherapeutic agents. Trends Immunol 22:414\u20137. https:\/\/doi.org\/10.1016\/S1471-4906(01)01985-8","journal-title":"Trends Immunol"},{"key":"4853_CR54","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1111\/jdv.16310","volume":"34","author":"ARJV Vossen","year":"2020","unstructured":"Vossen\u00a0ARJV, van Straalen\u00a0KR, Swagemakers\u00a0SMA et al (2020) A novel nicastrin mutation in a\u00a0three-generation Dutch family with hidradenitis suppurativa: a\u00a0search for functional significance. J\u00a0Eur Acad Dermatol Venereol 34:2353\u20132361. https:\/\/doi.org\/10.1111\/jdv.16310","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4853_CR55","doi-asserted-by":"publisher","DOI":"10.1159\/000512455","author":"Z Wang","year":"2020","unstructured":"Wang\u00a0Z, Yan\u00a0Y, Wang\u00a0B (2020) \u03b3\u2011secretase genetics of hidradenitis suppurativa: a systematic literature review. Dermatology. https:\/\/doi.org\/10.1159\/000512455","journal-title":"Dermatology"},{"key":"4853_CR56","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1046\/j.1365-2133.2000.03476.x","volume":"142","author":"JM Von der Werth","year":"2000","unstructured":"Von der Werth\u00a0JM, Williams\u00a0HC, Raeburn\u00a0JA (2000) The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol 142:947\u2013953. https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03476.x","journal-title":"Br J Dermatol"},{"key":"4853_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14141","author":"SC Williams","year":"2020","unstructured":"Williams\u00a0SC, Frew\u00a0JW, Krueger\u00a0JG (2020) A systematic review and critical appraisal of metagenomic and culture studies in hidradenitis suppurativa. Exp Dermatol. https:\/\/doi.org\/10.1111\/exd.14141","journal-title":"Exp Dermatol"},{"key":"4853_CR58","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jid.2018.11.018","volume":"139","author":"E Witte-H\u00e4ndel","year":"2019","unstructured":"Witte-H\u00e4ndel\u00a0E, Wolk\u00a0K, Tsaousi\u00a0A et al (2019) The IL\u20111 pathway is hyperactive in hidradenitis suppurativa and contributes to skin infiltration and destruction. J\u00a0Invest Dermatol 139:1294\u20131305. https:\/\/doi.org\/10.1016\/j.jid.2018.11.018","journal-title":"J Invest Dermatol"},{"key":"4853_CR59","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1365-2249.2006.03248.x","volume":"147","author":"X Wittebole","year":"2007","unstructured":"Wittebole\u00a0X, Hahm\u00a0S, Coyle\u00a0SM et\u00a0al (2007) Nicotine exposure alters in vivo human responses to endotoxin. Clin Exp Immunol 147:28\u201334. https:\/\/doi.org\/10.1111\/j.1365-2249.2006.03248.x","journal-title":"Clin Exp Immunol"},{"key":"4853_CR60","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19795","author":"K Wolk","year":"2021","unstructured":"Wolk\u00a0K, Brembach\u00a0TC, \u0160imait\u0117\u00a0D et al (2021) Activity and components of the granulocyte colony-stimulating factor pathway in hidradenitis suppurativa. Br J Dermatol. https:\/\/doi.org\/10.1111\/bjd.19795","journal-title":"Br J Dermatol"},{"key":"4853_CR61","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/bjd.19556","volume":"183","author":"K Wolk","year":"2020","unstructured":"Wolk\u00a0K, Join-Lambert\u00a0O, Sabat\u00a0R (2020) Aetiology and pathogenesis of hidradenitis suppurativa. Br J Dermatol 183:999\u20131010. https:\/\/doi.org\/10.1111\/bjd.19556","journal-title":"Br J Dermatol"},{"key":"4853_CR62","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","volume":"21","author":"K Wolk","year":"2004","unstructured":"Wolk\u00a0K, Kunz\u00a0S, Witte\u00a0E et al (2004) IL-22 increases the innate immunity of tissues. Immunity 21:241\u2013254. https:\/\/doi.org\/10.1016\/j.immuni.2004.07.007","journal-title":"Immunity"},{"key":"4853_CR63","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11154-016-9381-0","volume":"17","author":"K Wolk","year":"2016","unstructured":"Wolk\u00a0K, Sabat\u00a0R (2016) Adipokines in psoriasis: an important link between skin inflammation and metabolic alterations. Rev Endocr Metab Disord 17:305\u2013317. https:\/\/doi.org\/10.1007\/s11154-016-9381-0","journal-title":"Rev Endocr Metab Disord"},{"key":"4853_CR64","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","volume":"186","author":"K Wolk","year":"2011","unstructured":"Wolk\u00a0K, Warszawska\u00a0K, Hoeflich\u00a0C et al (2011) Deficiency of IL-22 contributes to a\u00a0chronic inflammatory disease: pathogenetic mechanisms in acne Inversa. J\u00a0Immunol 186:1228\u20131239. https:\/\/doi.org\/10.4049\/jimmunol.0903907","journal-title":"J Immunol"},{"key":"4853_CR65","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/bjd.15424","volume":"177","author":"K Wolk","year":"2017","unstructured":"Wolk\u00a0K, Wenzel\u00a0J, Tsaousi\u00a0A et al (2017) Lipocalin\u20112 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa\/hidradenitis suppurativa. Br J Dermatol 177:1385\u20131393. https:\/\/doi.org\/10.1111\/bjd.15424","journal-title":"Br J Dermatol"},{"key":"4853_CR66","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/bjd.14268","volume":"174","author":"H Xu","year":"2016","unstructured":"Xu\u00a0H, Xiao\u00a0X, Hui\u00a0Y et\u00a0al (2016) Phenotype of 53 Chinese individuals with nicastrin gene mutations in association with familial hidradenitis suppurativa (acne inversa). Br J Dermatol 174:927\u2013929. https:\/\/doi.org\/10.1111\/bjd.14268","journal-title":"Br J Dermatol"},{"key":"4853_CR67","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14214","author":"CC Zouboulis","year":"2020","unstructured":"Zouboulis\u00a0CC, Benhadou\u00a0F, Byrd\u00a0AS et\u00a0al (2020) What causes hidradenitis suppurativa\u202f?\u201415\u00a0years after. Exp Dermatol. https:\/\/doi.org\/10.1111\/exd.14214","journal-title":"Exp Dermatol"},{"key":"4853_CR68","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","volume":"29","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis\u00a0CC, Desai\u00a0N, Emtestam\u00a0L et\u00a0al (2015) European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa. J\u00a0Eur Acad Dermatol Venereol 29:619\u2013644. https:\/\/doi.org\/10.1111\/jdv.12966","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4853_CR69","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/exd.14338","volume":"30","author":"CC Zouboulis","year":"2021","unstructured":"Zouboulis CC, Frew JW, Giamarellos-Bourboulis EJ et al (2021) Target molecules for future hidradenitis suppurativa treatment. Exp Dermatol 30:8\u201317. https:\/\/doi.org\/10.1111\/exd.14338","journal-title":"Exp Dermatol"},{"key":"4853_CR70","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000431175","volume":"231","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis\u00a0CC, Del Marmol\u00a0V, Mrowietz\u00a0U et\u00a0al (2015) Hidradenitis suppurativa\/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation. Dermatology 231:184\u2013190. https:\/\/doi.org\/10.1159\/000431175","journal-title":"Dermatology"},{"key":"4853_CR71","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16264","author":"CC Zouboulis","year":"2020","unstructured":"Zouboulis\u00a0CC, Nogueira da Costa\u00a0A, Fimmel\u00a0S, Zouboulis\u00a0KC (2020) Apocrine glands are bystanders in hidradenitis suppurativa and their involvement is gender specific. J\u00a0Eur Acad Dermatol Venereol. https:\/\/doi.org\/10.1111\/jdv.16264","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4853_CR72","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/jdv.16147","volume":"34","author":"CC Zouboulis","year":"2020","unstructured":"Zouboulis\u00a0CC, Nogueira da Costa\u00a0A, Makrantonaki\u00a0E et\u00a0al (2020) Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa. J\u00a0Eur Acad Dermatol Venereol 34:846\u2013861. https:\/\/doi.org\/10.1111\/jdv.16147","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4853_CR73","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fmed.2017.00016","volume":"4","author":"R Higgins","year":"2017","unstructured":"Higgins\u00a0R, Pink\u00a0A, Hunger\u00a0R et\u00a0al (2017) Generalized comedones, acne, and Hidradenitis Suppurativa in a\u00a0patient with an FGFR2 missense mutation. Front Med 4:16. https:\/\/doi.org\/10.3389\/fmed.2017.00016","journal-title":"Front Med"},{"key":"4853_CR74","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1111\/jdv.14860","volume":"32","author":"P Marzuillo","year":"2018","unstructured":"Marzuillo\u00a0P, Piccolo\u00a0V, Mascolo\u00a0M et\u00a0al (2018) Patients affected by dent disease 2 could be predisposed to hidradenitis suppurativa. J\u00a0Eur Acad Dermatol Venereol 32:e309\u2013e311. https:\/\/doi.org\/10.1111\/jdv.14860","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4853_CR75","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2340\/00015555-1557","volume":"93","author":"JE Kim","year":"2013","unstructured":"Kim JE, Cho BK, Cho DH, et\u00a0al (2013) Expression of Hypothalamic-pituitary-adrenal axis in common skin diseases:Evidence of its association with stress-related Disease Activity. Acta Derm Venereol 93:387\u201393. https:\/\/doi.org\/10.2340\/00015555-1557","journal-title":"Acta Derm Venereol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04853-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-021-04853-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04853-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T03:04:36Z","timestamp":1627527876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-021-04853-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":75,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["4853"],"URL":"https:\/\/doi.org\/10.1007\/s00105-021-04853-x","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,6]]},"assertion":[{"value":"1 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"G.\u00a0Nikolakis, G.\u00a0Kokolakis, K.\u00a0Kaleta und R.\u00a0Hunger geben an, dass kein Interessenkonflikt besteht. K.\u00a0Wolk erhielt Projektunterst\u00fctzung, Auszeichnungen oder Verg\u00fctung f\u00fcr T\u00e4tigkeiten im Rahmen klinischer Studien, Referenten- oder Beratert\u00e4tigkeiten von folgenden Firmen (in alphabetischer Reihenfolge): AbbVie, Biogen IDEC, Bristol Myers Squibb, Celgene, Charit\u00e9 Research Organisation, Dr. Willmar Schwabe, Flexopharm, Janssen-Cilag, Novartis Pharma, Pfizer, Sanofi-Aventis, TFS Trial Form Support und UCB Pharma. R.\u00a0Sabat erhielt Projektunterst\u00fctzung, Auszeichnungen oder Verg\u00fctung f\u00fcr T\u00e4tigkeiten im Rahmen klinischer Studien, Referenten- oder Beratert\u00e4tigkeiten von folgenden Firmen (in alphabetischer Reihenfolge): AbbVie, AMGEN, Bayer, Biogen IDEC, Boehringer Ingelheim Pharma, Bristol Myers Squibb, Celgene, Charit\u00e9 Research Organisation, CSL Behring, Dr. Willmar Schwabe, Flexopharm, Janssen-Cilag, La Roche-Posay Laboratoire Dermatologique, Novartis Pharma, Parexel, Pfizer, Sanofi-Aventis, TFS Trial Form Support und UCB Pharma. C.C.\u00a0Zouboulis hat Berater- und Vortragshonorare von Idorsia, Incyte, InflaRx, Janssen, Novartis, Regeneron und UCB erhalten, die nicht mit diesem Manuskript in Verbindung stehen. Seine Abteilung erhielt Honorare von AbbVie, InflaRx, Novartis und UCB f\u00fcr seine Teilnahme an klinischen Studien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}